MRK Long Put Strategy

MRK (Merck & Co., Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV.

MRK (Merck & Co., Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $280.20B, a trailing P/E of 31.39, a beta of 0.20 versus the broader market, a 52-week range of 73.31-125.14, average daily share volume of 9.7M, a public-listing history dating back to 1978, approximately 73K full-time employees. These structural characteristics shape how MRK stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.20 indicates MRK has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. MRK pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a long put on MRK?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current MRK snapshot

As of May 15, 2026, spot at $111.64, ATM IV 29.27%, IV rank 46.00%, expected move 8.39%. The long put on MRK below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this long put structure on MRK specifically: MRK IV at 29.27% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 8.39% (roughly $9.37 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MRK expiries trade a higher absolute premium for lower per-day decay. Position sizing on MRK should anchor to the underlying notional of $111.64 per share and to the trader's directional view on MRK stock.

MRK long put setup

The MRK long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MRK near $111.64, the first option leg uses a $112.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MRK chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MRK shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$112.00$3.65

MRK long put risk and reward

Net Premium / Debit
-$365.00
Max Profit (per contract)
$10,834.00
Max Loss (per contract)
-$365.00
Breakeven(s)
$108.35
Risk / Reward Ratio
29.682

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

MRK long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on MRK. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$10,834.00
$24.69-77.9%+$8,365.69
$49.38-55.8%+$5,897.38
$74.06-33.7%+$3,429.07
$98.74-11.6%+$960.75
$123.43+10.6%-$365.00
$148.11+32.7%-$365.00
$172.79+54.8%-$365.00
$197.47+76.9%-$365.00
$222.16+99.0%-$365.00

When traders use long put on MRK

Long puts on MRK hedge an existing long MRK stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying MRK exposure being hedged.

MRK thesis for this long put

The market-implied 1-standard-deviation range for MRK extends from approximately $102.27 on the downside to $121.01 on the upside. A MRK long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long MRK position with one put per 100 shares held. Current MRK IV rank near 46.00% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on MRK should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MRK options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MRK-specific events.

MRK long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MRK positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MRK alongside the broader basket even when MRK-specific fundamentals are unchanged. Long-premium structures like a long put on MRK are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MRK chain quotes before placing a trade.

Frequently asked questions

What is a long put on MRK?
A long put on MRK is the long put strategy applied to MRK (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With MRK stock trading near $111.64, the strikes shown on this page are snapped to the nearest listed MRK chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are MRK long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the MRK long put priced from the end-of-day chain at a 30-day expiry (ATM IV 29.27%), the computed maximum profit is $10,834.00 per contract and the computed maximum loss is -$365.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MRK long put?
The breakeven for the MRK long put priced on this page is roughly $108.35 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MRK market-implied 1-standard-deviation expected move is approximately 8.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on MRK?
Long puts on MRK hedge an existing long MRK stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying MRK exposure being hedged.
How does current MRK implied volatility affect this long put?
MRK ATM IV is at 29.27% with IV rank near 46.00%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related MRK analysis